Discover our unique LentiVector™ platform

Our Services

We provide a flexible service offering designed to support you wherever you are in your development journey – whether you are in early phase or ready for commercial GMP manufacturing.

• Construct & Plasmid Design
• Analytical Method Development
• Process Development
• GMP Cell Banking
• GMP Manufacturing
• QA Release
• Stability Studies
• Regulatory Support

The LentiVector™ platform

The LentiVector™ platform is the world’s first lentiviral-based gene delivery system to be commercially approved. The platform can provide:

• Optimised processes producing higher titers of drug substance per batch than traditional processes
• Reliable commercial quality, notably supporting the first FDA approved CAR-T cell therapy
• Best-in-class perfusion bioreactor process that offers superior yield and quality
• An established serum-free suspension bioreactor process
• Automated product-specific design of experiment
• Minimal 3rd generation vector systems with key safety features
• Expertise with different lentiviral-based vectors (HIV, SIV, EIAV) and using various pseudotypes to target specific cells
• Large suite of in-house analytical methods recognised by regulatory bodies for an accelerated GMP batch release
• Access to unique chemical and mRNA enhancers to boost productivity
• 4th generation lentiviral vector system offering higher quality and potency
• Optimised cell lines for a scalable manufacturing process